Open AccessA New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study
Author(s) -
Hong Liang,
Antoine Labbé,
Jeannie Le Mouhaër,
Céline Plisson,
Christophe Baudouin
Publication year - 2017
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.16-21080
Subject(s) - cystinosis , cystine , photophobia , blurred vision , cysteamine , adverse effect , medicine , ophthalmology , eye drop , chemistry , pharmacology , biochemistry , cysteine , enzyme
The purpose of this study was to evaluate the efficacy of new viscous cysteamine hydrochloride (CH) eye drops (vCH 0.55%) compared with standard CH 0.10% drops treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom